Shuttle Pharmaceuticals
SHPH
8 hedge funds and large institutions have $265K invested in Shuttle Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, 3 reducing their positions, and 5 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
11% less funds holding
Funds holding: 9 → 8 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
89% less capital invested
Capital invested by funds: $2.32M → $265K (-$2.05M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG Americas Securities
New York
|
+$38.9K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$38.9K |
| 3 |
Goldman Sachs
New York
|
+$29.2K |
| 4 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$4.86K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.41M |
| 2 |
Jane Street
New York
|
-$96K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$82.6K |
| 4 |
HSBC Holdings
London,
United Kingdom
|
-$67K |
| 5 |
Two Sigma Investments
New York
|
-$48.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Qube Research & Technologies (QRT)
London,
United Kingdom
| $76.6K | – | – | – |
|
2
Millennium Management
New York
| $41K | -$24.3K | -5 | -33% |
|
|
3
SG Americas Securities
New York
| $33K | +$38.9K | +8 | New |
|
|
TSS
4
Two Sigma Securities
New York
| $32.3K | +$38.9K | +8 | New |
|
|
VF
5
Virtu Financial
New York
| $31K | -$4.86K | -1 | -11% |
|
|
6
Goldman Sachs
New York
| $24.4K | +$29.2K | +6 | New |
|
|
7
Two Sigma Investments
New York
| $23.1K | -$48.6K | -10 | -63% |
|
|
FDCDDQ
8
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $2.35K | +$4.86K | +1 | New |
|
|
9
UBS Group
Zurich,
Switzerland
| $951 | -$82.6K | -17 | Closed |
|
|
10
BlackRock
New York
| – | -$1.41M | -154 | Closed |
|
|
11
Jane Street
New York
| – | -$96K | -10 | Closed |
|
|
12
HSBC Holdings
London,
United Kingdom
| – | -$67K | -7 | Closed |
|
13
Barclays
London,
United Kingdom
| – | -$39K | -4 | Closed |
|
SHPH Hedge Fund Activity: Q4 2022 in Review
8 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Shuttle Pharmaceuticals (SHPH) for Q4 2022, worth a combined $265K — down 89% from $2.32M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of SHPH and 4 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 0 added.
The largest buyer was SG Americas Securities, opening a new position worth an estimated $38.9K. The largest seller was BlackRock, exiting entirely with an estimated $1.41M sold.
- 8 institutional investors held Shuttle Pharmaceuticals (SHPH) as of Q4 2022, down from 9 in Q3 2022.
- Funds reported $265K of Shuttle Pharmaceuticals stock for Q4 2022, down 89% quarter-over-quarter.
- 4 funds opened new Shuttle Pharmaceuticals positions in Q4 2022 and 5 closed out, a net change of -1 holder.
- The largest Shuttle Pharmaceuticals buyer in Q4 2022 was SG Americas Securities, an estimated $38.9K added.
- The largest Shuttle Pharmaceuticals seller in Q4 2022 was BlackRock, an estimated $1.41M sold.
Based on aggregated 13F filings for Q4 2022.